Related Experiment Videos
Changes in the isoprenoid pathway in syndrome X
Summary
Metabolic syndrome X alters isoprenoid pathway metabolites, increasing digoxin and affecting RBC membrane function. These changes, along with altered amino acid metabolism and mineral levels, contribute to syndrome X symptoms.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Cellular Biology
Background:
- Metabolic syndrome X is characterized by multiple lacunar states.
- The isoprenoid pathway plays a crucial role in cellular metabolism.
- Dysregulation of this pathway may contribute to the pathophysiology of metabolic syndrome X.
Purpose of the Study:
- To investigate alterations in digoxin and isoprenoid pathway metabolites in metabolic syndrome X.
- To correlate these metabolic changes with membrane function and cellular processes.
- To elucidate the biochemical mechanisms underlying the symptoms of syndrome X.
Main Methods:
- Assessed plasma HMG CoA reductase activity.
- Measured serum levels of digoxin, tryptophan, tyrosine, magnesium, dolichol, and ubiquinone.
- Evaluated RBC membrane Na+-K+ ATPase activity.
- Analyzed changes in glycosaminoglycans, glycoproteins, and lipid composition.
Main Results:
- Increased HMG CoA reductase activity and serum digoxin led to reduced RBC Na+-K+ ATPase activity.
- Altered serum levels of tryptophan and tyrosine metabolites were observed.
- Decreased serum magnesium impacted glycosaminoglycan and glycolipid metabolism.
- Increased dolichol and decreased ubiquinone affected glycoprotein metabolism and free radical generation, respectively.
- Observed changes in membrane composition contributed to decreased lysosomal stability.
Conclusions:
- Digoxin-induced Na+-K+ ATPase inhibition, altered metabolite levels, and changes in membrane composition contribute to increased intracellular calcium and reduced magnesium.
- These biochemical alterations provide a mechanistic explanation for the clinical manifestations of metabolic syndrome X.